A Longitudinal Study Reveals Metabolomic Markers for Individuals at Risk, Disease Severity, and Treatment Response in Rheumatoid Arthritis.
Zhu C, Xu J, He S, Niu Q, Liu Y, Guo X, Hu H, Sun R, Chen T, Liu Y, Xu Z, Jiang N, Yao L, Dai L, Zou Q, Zeng F, Meng L, Gjertsson I, Holmdahl R, Yang B, Du D, Zhao Y.
Zhu C, et al. Among authors: sun r.
Adv Sci (Weinh). 2025 Aug 13:e04414. doi: 10.1002/advs.202504414. Online ahead of print.
Adv Sci (Weinh). 2025.
PMID: 40801465